[HTML][HTML] Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

V Panwar, A Singh, M Bhatt, RK Tonk… - Signal transduction and …, 2023 - nature.com
The mammalian target of rapamycin (mTOR) is a protein kinase that controls cellular
metabolism, catabolism, immune responses, autophagy, survival, proliferation, and …

LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer

YT Tan, JF Lin, T Li, JJ Li, RH Xu… - Cancer …, 2021 - Wiley Online Library
Altered metabolism is a hallmark of cancer, and the reprogramming of energy metabolism
has historically been considered a general phenomenon of tumors. It is well recognized that …

[HTML][HTML] The role of ubiquitination and deubiquitination in cancer metabolism

T Sun, Z Liu, Q Yang - Molecular cancer, 2020 - Springer
Metabolic reprogramming, including enhanced biosynthesis of macromolecules, altered
energy metabolism, and maintenance of redox homeostasis, is considered a hallmark of …

Cancer metabolism and tumor microenvironment: fostering each other?

Y Yuan, H Li, W Pu, L Chen, D Guo, H Jiang… - Science China Life …, 2022 - Springer
The changes associated with malignancy are not only in cancer cells but also in
environment in which cancer cells live. Metabolic reprogramming supports tumor cell high …

[HTML][HTML] DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

C Lu, Y Wei, X Wang, Z Zhang, J Yin, W Li, L Chen… - Molecular cancer, 2020 - Springer
Background Accumulating evidence shows that long noncoding RNAs (lncRNAs) are
important regulator molecules involved in diverse biological processes. Acquired drug …

[HTML][HTML] Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies

Y Zhang, Q Li, Z Huang, B Li, EC Nice, C Huang, L Wei… - Cancers, 2022 - mdpi.com
Simple Summary Reprogramming of glucose metabolism is a hallmark of cancer and can be
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …

[HTML][HTML] The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges

S Xie, Z Wu, Y Qi, B Wu, X Zhu - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Lung cancer is one of the common malignant tumors that threaten human life with serious
incidence and high mortality. According to the histopathological characteristics, lung cancer …

[HTML][HTML] Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression

X Zang, J Gu, J Zhang, H Shi, S Hou, X Xu… - Cell death & …, 2020 - nature.com
Abstract Long non-coding RNAs (LncRNAs) have been suggested as important regulators of
cancer development and progression in non-small cell lung cancer (NSCLC). Nevertheless …

Long noncoding RNA MALAT1 regulates cancer glucose metabolism by enhancing mTOR-mediated translation of TCF7L2

P Malakar, I Stein, A Saragovi, R Winkler… - Cancer research, 2019 - AACR
Reprogrammed glucose metabolism of enhanced aerobic glycolysis (or the Warburg effect)
is known as a hallmark of cancer. The roles of long noncoding RNAs (lncRNA) in regulating …

[HTML][HTML] Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy

Q Cai, S Wang, L Jin, M Weng, D Zhou, J Wang… - Molecular cancer, 2019 - Springer
Background Gallbladder cancer is the most common biliary tract malignancy and not
sensitive to chemotherapy. Autophagy is an important factor prolonging the survival of …